SEC FORM 3/A

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Clem Kerry M

(Last)

(First)

(Middle)

420 SAW MILL RIVER ROAD

(Street)

ARDSLEY

10502

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/09/2021

3. Issuer Name and Ticker or Trading Symbol
ACORDA THERAPEUTICS INC [ ACOR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
09/20/2021

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	11,594⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽²⁾	03/15/2022	Common Stock	3,000	158.1	D
Employee Stock Option (right to buy)	⁽³⁾	03/06/2023	Common Stock	3,543	182.76	D
Employee Stock Option (right to buy)	⁽⁴⁾	03/05/2024	Common Stock	3,543	236.28	D
Employee Stock Option (right to buy)	⁽⁵⁾	03/04/2025	Common Stock	3,188	214.44	D
Employee Stock Option (right to buy)	⁽⁶⁾	03/02/2026	Common Stock	2,159	213.18	D
Employee Stock Option (right to buy)	⁽⁷⁾	03/01/2027	Common Stock	1,250	164.85	D
Employee Stock Option (right to buy)	⁽⁷⁾	03/01/2028	Common Stock	1,967	146.1	D
Employee Stock Option (right to buy)	⁽⁸⁾	03/08/2029	Common Stock	1,834	81.06	D
Employee Stock Option (right to buy)	⁽⁹⁾	11/07/2029	Common Stock	9,168	14.46	D
Employee Stock Option (right to buy)	⁽¹⁰⁾	09/01/2030	Common Stock	2,501	3.1572	D

Explanation of Responses:

1. Includes 550 unvested restricted stock awards and 6,675 unvested restricted stock unit awards issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. 275 of the restricted stock awards vest on December 1, 2021 and 275 vest on December 1, 2022, subject to continued service. The restricted stock units each represent a contingent right to one share of the Issuer's common stock, subject to continued service, vesting in installments of 20% and 40% on March 3, 2022 and September 3, 2022, respectively.

2. Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2016.

3. Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2017.

4. Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2018.

5. Options issued under the Issuer's 2006 Employee Incentive Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2019.

6. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2020.

7. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vested in installments and were fully vested on January 1, 2021.

8. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2019, with the first quarterly installment vesting on April 1, 2019.

9. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over two years beginning on November 7, 2019, with the first quarterly installment vesting on February 7, 2020.

10. Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option vest in equal quarterly installments over four years beginning on September 1, 2020, with the first quarterly installment vesting on December 1, 2020.

Remarks:

This amendment is refiled due to incorrect Power of Attorney on the initial Form 3 filing.

	/s/ Kerry M. Clem	09/20/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.